Literature DB >> 34591612

A protein interaction landscape of breast cancer.

Minkyu Kim1,2,3,4, Jisoo Park4,5, Mehdi Bouhaddou1,2,3,4, Kyumin Kim1,2,3,4, Ajda Rojc1,2,3,4, Maya Modak1,2,3,4, Margaret Soucheray1,2,3,4, Michael J McGregor1,2,3,4, Patrick O'Leary4,6, Denise Wolf4,6, Erica Stevenson1,2,3,4, Tzeh Keong Foo7, Dominique Mitchell3,6,8, Kari A Herrington9, Denise P Muñoz4,6, Beril Tutuncuoglu1,2,3,4, Kuei-Ho Chen1,2,3,4, Fan Zheng4,5, Jason F Kreisberg4,5, Morgan E Diolaiti4,6, John D Gordan3,6,8, Jean-Philippe Coppé4,6, Danielle L Swaney1,2,3,4, Bing Xia7, Laura van 't Veer4,6, Alan Ashworth4,6, Trey Ideker4,5,10, Nevan J Krogan1,2,3,4.   

Abstract

Cancers have been associated with a diverse array of genomic alterations. To help mechanistically understand such alterations in breast-invasive carcinoma, we applied affinity purification–mass spectrometry to delineate comprehensive biophysical interaction networks for 40 frequently altered breast cancer (BC) proteins, with and without relevant mutations, across three human breast cell lines. These networks identify cancer-specific protein-protein interactions (PPIs), interconnected and enriched for common and rare cancer mutations, that are substantially rewired by the introduction of key BC mutations. Our analysis identified BPIFA1 and SCGB2A1 as PIK3CA-interacting proteins, which repress PI3K-AKT signaling, and uncovered USP28 and UBE2N as functionally relevant interactors of BRCA1. We also show that the protein phosphatase 1 regulatory subunit spinophilin interacts with and regulates dephosphorylation of BRCA1 to promote DNA double-strand break repair. Thus, PPI landscapes provide a powerful framework for mechanistically interpreting disease genomic data and can identify valuable therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34591612      PMCID: PMC9040556          DOI: 10.1126/science.abf3066

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   63.714


  131 in total

1.  A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy.

Authors:  Huaxian Chen; Joy Kovar; Sean Sissons; Karen Cox; William Matter; Fred Chadwell; Peng Luan; Chris J Vlahos; Amy Schutz-Geschwender; D Michael Olive
Journal:  Anal Biochem       Date:  2005-03-01       Impact factor: 3.365

2.  Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis.

Authors:  Priya S Shah; Nichole Link; Gwendolyn M Jang; Phillip P Sharp; Tongtong Zhu; Danielle L Swaney; Jeffrey R Johnson; John Von Dollen; Holly R Ramage; Laura Satkamp; Billy Newton; Ruth Hüttenhain; Marine J Petit; Tierney Baum; Amanda Everitt; Orly Laufman; Michel Tassetto; Michael Shales; Erica Stevenson; Gabriel N Iglesias; Leila Shokat; Shashank Tripathi; Vinod Balasubramaniam; Laurence G Webb; Sebastian Aguirre; A Jeremy Willsey; Adolfo Garcia-Sastre; Katherine S Pollard; Sara Cherry; Andrea V Gamarnik; Ivan Marazzi; Jack Taunton; Ana Fernandez-Sesma; Hugo J Bellen; Raul Andino; Nevan J Krogan
Journal:  Cell       Date:  2018-12-13       Impact factor: 41.582

Review 3.  Mapping the protein-protein and genetic interactions of cancer to guide precision medicine.

Authors:  Mehdi Bouhaddou; Manon Eckhardt; Zun Zar Chi Naing; Minkyu Kim; Trey Ideker; Nevan J Krogan
Journal:  Curr Opin Genet Dev       Date:  2019-07-06       Impact factor: 5.578

4.  Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen.

Authors:  Ildiko Unk; Ildikó Hajdú; Károly Fátyol; Barnabás Szakál; András Blastyák; Vladimir Bermudez; Jerard Hurwitz; Louise Prakash; Satya Prakash; Lajos Haracska
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

5.  BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

Authors:  Rinske Drost; Kiranjit K Dhillon; Hanneke van der Gulden; Ingrid van der Heijden; Inger Brandsma; Cristina Cruz; Dafni Chondronasiou; Marta Castroviejo-Bermejo; Ute Boon; Eva Schut; Eline van der Burg; Ellen Wientjens; Mark Pieterse; Christiaan Klijn; Sjoerd Klarenbeek; Fabricio Loayza-Puch; Ran Elkon; Liesbeth van Deemter; Sven Rottenberg; Marieke van de Ven; Dick H W Dekkers; Jeroen A A Demmers; Dik C van Gent; Reuven Agami; Judith Balmaña; Violeta Serra; Toshiyasu Taniguchi; Peter Bouwman; Jos Jonkers
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

6.  The BRCT domain is a phospho-protein binding domain.

Authors:  Xiaochun Yu; Claudia Christiano Silva Chini; Miao He; Georges Mer; Junjie Chen
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

7.  The landscape of cancer genes and mutational processes in breast cancer.

Authors:  Philip J Stephens; Patrick S Tarpey; Helen Davies; Peter Van Loo; Chris Greenman; David C Wedge; Serena Nik-Zainal; Sancha Martin; Ignacio Varela; Graham R Bignell; Lucy R Yates; Elli Papaemmanuil; David Beare; Adam Butler; Angela Cheverton; John Gamble; Jonathan Hinton; Mingming Jia; Alagu Jayakumar; David Jones; Calli Latimer; King Wai Lau; Stuart McLaren; David J McBride; Andrew Menzies; Laura Mudie; Keiran Raine; Roland Rad; Michael Spencer Chapman; Jon Teague; Douglas Easton; Anita Langerød; Ming Ta Michael Lee; Chen-Yang Shen; Benita Tan Kiat Tee; Bernice Wong Huimin; Annegien Broeks; Ana Cristina Vargas; Gulisa Turashvili; John Martens; Aquila Fatima; Penelope Miron; Suet-Feung Chin; Gilles Thomas; Sandrine Boyault; Odette Mariani; Sunil R Lakhani; Marc van de Vijver; Laura van 't Veer; John Foekens; Christine Desmedt; Christos Sotiriou; Andrew Tutt; Carlos Caldas; Jorge S Reis-Filho; Samuel A J R Aparicio; Anne Vincent Salomon; Anne-Lise Børresen-Dale; Andrea L Richardson; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

8.  Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types.

Authors:  K Yu; B Chen; D Aran; J Charalel; C Yau; D M Wolf; L J van 't Veer; A J Butte; T Goldstein; M Sirota
Journal:  Nat Commun       Date:  2019-08-08       Impact factor: 14.919

9.  Integrative pathway enrichment analysis of multivariate omics data.

Authors:  Marta Paczkowska; Jonathan Barenboim; Nardnisa Sintupisut; Natalie S Fox; Helen Zhu; Diala Abd-Rabbo; Miles W Mee; Paul C Boutros; Jüri Reimand
Journal:  Nat Commun       Date:  2020-02-05       Impact factor: 14.919

10.  A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.

Authors:  John D Carpten; Andrew L Faber; Candice Horn; Gregory P Donoho; Stephen L Briggs; Christiane M Robbins; Galen Hostetter; Sophie Boguslawski; Tracy Y Moses; Stephanie Savage; Mark Uhlik; Aimin Lin; Jian Du; Yue-Wei Qian; Douglas J Zeckner; Greg Tucker-Kellogg; Jeffrey Touchman; Ketan Patel; Spyro Mousses; Michael Bittner; Richard Schevitz; Mei-Huei T Lai; Kerry L Blanchard; James E Thomas
Journal:  Nature       Date:  2007-07-04       Impact factor: 69.504

View more
  8 in total

1.  Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies.

Authors:  Denise M Wolf; Christina Yau; Julia Wulfkuhle; Lamorna Brown-Swigart; Rosa I Gallagher; Pei Rong Evelyn Lee; Zelos Zhu; Mark J Magbanua; Rosalyn Sayaman; Nicholas O'Grady; Amrita Basu; Amy Delson; Jean Philippe Coppé; Ruixiao Lu; Jerome Braun; Smita M Asare; Laura Sit; Jeffrey B Matthews; Jane Perlmutter; Nola Hylton; Minetta C Liu; Paula Pohlmann; W Fraser Symmans; Hope S Rugo; Claudine Isaacs; Angela M DeMichele; Douglas Yee; Donald A Berry; Lajos Pusztai; Emanuel F Petricoin; Gillian L Hirst; Laura J Esserman; Laura J van 't Veer
Journal:  Cancer Cell       Date:  2022-05-26       Impact factor: 38.585

2.  Discovering gene regulatory networks of multiple phenotypic groups using dynamic Bayesian networks.

Authors:  Polina Suter; Jack Kuipers; Niko Beerenwinkel
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

3.  Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.

Authors:  Pierre C Havugimana; Raghuveera Kumar Goel; Sadhna Phanse; Ahmed Youssef; Dzmitry Padhorny; Sergei Kotelnikov; Dima Kozakov; Andrew Emili
Journal:  Nat Commun       Date:  2022-07-13       Impact factor: 17.694

4.  Data-dependent visualization of biological networks in the web-browser with NDExEdit.

Authors:  Florian Auer; Simone Mayer; Frank Kramer
Journal:  PLoS Comput Biol       Date:  2022-06-08       Impact factor: 4.779

5.  Interpretation of cancer mutations using a multiscale map of protein systems.

Authors:  Fan Zheng; Marcus R Kelly; Dana J Ramms; Marissa L Heintschel; Kai Tao; Beril Tutuncuoglu; John J Lee; Keiichiro Ono; Helene Foussard; Michael Chen; Kari A Herrington; Erica Silva; Sophie N Liu; Jing Chen; Christopher Churas; Nicholas Wilson; Anton Kratz; Rudolf T Pillich; Devin N Patel; Jisoo Park; Brent Kuenzi; Michael K Yu; Katherine Licon; Dexter Pratt; Jason F Kreisberg; Minkyu Kim; Danielle L Swaney; Xiaolin Nan; Stephanie I Fraley; J Silvio Gutkind; Nevan J Krogan; Trey Ideker
Journal:  Science       Date:  2021-10-01       Impact factor: 63.714

Review 6.  From systems to structure - using genetic data to model protein structures.

Authors:  Hannes Braberg; Ignacia Echeverria; Robyn M Kaake; Andrej Sali; Nevan J Krogan
Journal:  Nat Rev Genet       Date:  2022-01-10       Impact factor: 59.581

7.  EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.

Authors:  Xin Fang; Nan Ni; Xiaofang Wang; Yanan Tian; Ivan Ivanov; Monique Rijnkels; Kayla J Bayless; John P Lydon; Qinglei Li
Journal:  Cells       Date:  2022-03-07       Impact factor: 7.666

8.  Gene utility recapitulates chromosomal aberrancies in advanced stage neuroblastoma.

Authors:  Choong Y Ung; Taylor M Levee; Cheng Zhang; Cristina Correia; Kok-Siong Yeo; Hu Li; Shizhen Zhu
Journal:  Comput Struct Biotechnol J       Date:  2022-06-20       Impact factor: 6.155

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.